Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumours.

Oncotarget · 2017 · PMC5722542 · PMID 29228590

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

This is indeed a strong trend, with 118 out of 127 drugs having a higher proportion of correctly predicted sensitive cell lines using the multi-gene markers.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.